Trending...
- Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
- Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
ALPHARETTA, Ga. - OhioPen -- PharmaCentra, LLC, a full-service U.S. based concierge contact center specializing in healthcare-focused patient, pharmacy, and physician communication services, is pleased to announce a strategic partnership with Cervey, LLC, a market leader in pharmacy technology solutions for health system pharmacies, specialty pharmacies, and pharmacy benefit managers (PBMs).
The collaboration combines Cervey's robust suite of technology solutions with PharmaCentra's high-touch communication services, providing scalable contact center services, seamlessly integrated within Cervey's pharmacy technology platforms.
"Our partnership with PharmaCentra is a powerful alignment of technology and human connection," says Trent Jackson, Senior Vice President of Cervey. "By leveraging our platforms alongside PharmaCentra's communication capabilities, we're expanding Cervey's ability to deliver end-to-end pharmacy solutions." This collaboration reflects Cervey's commitment to delivering innovative, client-centered solutions that simplify complexity and strengthen connections across the healthcare landscape.
More on Ohio Pen
PharmaCentra brings decades of experience delivering customized outreach and support programs tailored to the evolving needs of PBMs, specialty pharmacies, hospitals, pharmaceutical manufacturers, and other healthcare organizations. Their team is already trained on Cervey's technology platforms, ensuring seamless onboarding and rapid deployment of support services.
"At PharmaCentra, we pride ourselves on being a true partner, one that listens, adapts, and delivers," said Dan Berman, CEO of PharmaCentra. "Joining forces with Cervey enables us to amplify our impact and offer clients a unified solution that blends cutting-edge technology with compassionate, expert-driven communication. This partnership delivers even greater value across the PBM, hospital, and specialty pharmacy space."
Since the launch of the partnership in late 2024, Cervey and PharmaCentra have actively collaborated to support healthcare organizations through tailored contact center programs built around Cervey's technology platforms. These efforts are already generating meaningful learnings and delivering actionable insights focusing on supporting patients and pharmacies, and helping healthcare clients improve access, communication, and operational efficiency.
More on Ohio Pen
About Cervey, LLC
Cervey, LLC, is a wholly owned subsidiary of M&D Holding Company. A leading provider of technology solutions for health system pharmacies, specialty pharmacies, and pharmacy benefit managers (PBMs), Cervey delivers innovative software that streamlines operations—from prescription claims processing to 340B compliance and clinical workflow management. With a commitment to transparency and open communication, Cervey has built lasting partnerships with its clients, helping them to simplify complex processes and enabling sustainable growth.
About PharmaCentra, LLC
PharmaCentra, LLC is a full-service concierge contact center offering expert pharmaceutical marketing and sales support, along with strategic patient, pharmacy, and physician outreach solutions. With proven capabilities in patient engagement, clinical trial recruitment, pharmacy and physician teledetailing, member support services, and more, PharmaCentra helps healthcare companies and pharmaceutical brands build stronger connections and improve healthcare access, adherence, and service across the continuum of care. Visit PharmaCentra.com for more information.
The collaboration combines Cervey's robust suite of technology solutions with PharmaCentra's high-touch communication services, providing scalable contact center services, seamlessly integrated within Cervey's pharmacy technology platforms.
"Our partnership with PharmaCentra is a powerful alignment of technology and human connection," says Trent Jackson, Senior Vice President of Cervey. "By leveraging our platforms alongside PharmaCentra's communication capabilities, we're expanding Cervey's ability to deliver end-to-end pharmacy solutions." This collaboration reflects Cervey's commitment to delivering innovative, client-centered solutions that simplify complexity and strengthen connections across the healthcare landscape.
More on Ohio Pen
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
PharmaCentra brings decades of experience delivering customized outreach and support programs tailored to the evolving needs of PBMs, specialty pharmacies, hospitals, pharmaceutical manufacturers, and other healthcare organizations. Their team is already trained on Cervey's technology platforms, ensuring seamless onboarding and rapid deployment of support services.
"At PharmaCentra, we pride ourselves on being a true partner, one that listens, adapts, and delivers," said Dan Berman, CEO of PharmaCentra. "Joining forces with Cervey enables us to amplify our impact and offer clients a unified solution that blends cutting-edge technology with compassionate, expert-driven communication. This partnership delivers even greater value across the PBM, hospital, and specialty pharmacy space."
Since the launch of the partnership in late 2024, Cervey and PharmaCentra have actively collaborated to support healthcare organizations through tailored contact center programs built around Cervey's technology platforms. These efforts are already generating meaningful learnings and delivering actionable insights focusing on supporting patients and pharmacies, and helping healthcare clients improve access, communication, and operational efficiency.
More on Ohio Pen
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Pataskala, Ohio Olde Town Holiday Cookie Walk 2025
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
About Cervey, LLC
Cervey, LLC, is a wholly owned subsidiary of M&D Holding Company. A leading provider of technology solutions for health system pharmacies, specialty pharmacies, and pharmacy benefit managers (PBMs), Cervey delivers innovative software that streamlines operations—from prescription claims processing to 340B compliance and clinical workflow management. With a commitment to transparency and open communication, Cervey has built lasting partnerships with its clients, helping them to simplify complex processes and enabling sustainable growth.
About PharmaCentra, LLC
PharmaCentra, LLC is a full-service concierge contact center offering expert pharmaceutical marketing and sales support, along with strategic patient, pharmacy, and physician outreach solutions. With proven capabilities in patient engagement, clinical trial recruitment, pharmacy and physician teledetailing, member support services, and more, PharmaCentra helps healthcare companies and pharmaceutical brands build stronger connections and improve healthcare access, adherence, and service across the continuum of care. Visit PharmaCentra.com for more information.
Source: PharmaCentra, LLC
0 Comments
Latest on Ohio Pen
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- Have a Ball with the Latest "Travels with Tony" Video
- Enter the Erma Bombeck Writing Competition!
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
- Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
- Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
- Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
- Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
- Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
- Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
- Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
- Spark Announces 2025 Design Award Winners
- NEW Luxury Single-Family Homes Coming Soon to Manalapan - Pre-Qualify Today for Priority Appointments
- Dominic Pace Returns to the NCIS Franchise With Guest Role on NCIS: Origins
- Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
- UK Financial Ltd Completes Full Ecosystem Conversion With Three New ERC-3643 SEC-Ready Tokens As MCAT Deadline Closes Tonight
